A detailed history of Tower Research Capital LLC (Trc) transactions in Standard Biotools Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,970 shares of LAB stock, worth $7,265. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,970
Holding current value
$7,265
% of portfolio
0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.42 - $2.35 $5,637 - $9,329
3,970 New
3,970 $7,000
Q1 2024

May 15, 2024

BUY
$1.87 - $2.78 $32,698 - $48,611
17,486 Added 187.68%
26,803 $72,000
Q4 2023

Feb 13, 2024

BUY
$1.59 - $2.73 $4,599 - $7,897
2,893 Added 45.03%
9,317 $20,000
Q3 2023

Nov 14, 2023

BUY
$1.9 - $3.05 $921 - $1,479
485 Added 8.17%
6,424 $18,000
Q2 2023

Aug 14, 2023

SELL
$1.47 - $2.56 $433 - $755
-295 Reduced 4.73%
5,939 $11,000
Q1 2023

May 09, 2023

SELL
$1.3 - $2.24 $22,475 - $38,727
-17,289 Reduced 73.5%
6,234 $12,000
Q4 2022

Feb 10, 2023

BUY
$0.93 - $1.52 $21,876 - $35,754
23,523 New
23,523 $28,000
Q2 2022

Aug 15, 2022

SELL
$1.6 - $3.99 $9,369 - $23,365
-5,856 Reduced 49.53%
5,967 $10,000
Q1 2022

May 12, 2022

SELL
$2.8 - $3.96 $75,320 - $106,524
-26,900 Reduced 69.47%
11,823 $42,000
Q4 2021

Feb 14, 2022

BUY
$3.63 - $6.13 $94,118 - $158,938
25,928 Added 202.64%
38,723 $152,000
Q3 2021

Nov 15, 2021

BUY
$5.5 - $7.41 $42,064 - $56,671
7,648 Added 148.59%
12,795 $84,000
Q2 2021

Aug 16, 2021

SELL
$4.35 - $6.35 $150,436 - $219,602
-34,583 Reduced 87.05%
5,147 $32,000
Q1 2021

May 17, 2021

BUY
$3.94 - $7.09 $113,479 - $204,206
28,802 Added 263.56%
39,730 $180,000
Q4 2020

Feb 16, 2021

SELL
$5.45 - $8.65 $361,242 - $573,347
-66,283 Reduced 85.85%
10,928 $65,000
Q3 2020

Nov 16, 2020

BUY
$4.34 - $11.43 $246,368 - $648,846
56,767 Added 277.67%
77,211 $574,000
Q2 2020

Aug 13, 2020

BUY
$1.85 - $5.29 $37,821 - $108,148
20,444 New
20,444 $82,000
Q4 2019

Feb 07, 2020

SELL
$2.3 - $5.12 $14,110 - $31,411
-6,135 Closed
0 $0
Q3 2019

Nov 05, 2019

BUY
$4.63 - $12.15 $28,270 - $74,187
6,106 Added 21055.17%
6,135 $29,000
Q2 2019

Aug 13, 2019

BUY
$11.49 - $14.17 $333 - $410
29 New
29 $0
Q1 2019

May 14, 2019

SELL
$8.47 - $14.36 $4,556 - $7,725
-538 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$7.18 - $8.83 $32,561 - $40,044
-4,535 Reduced 89.39%
538 $5,000
Q3 2018

Nov 13, 2018

BUY
$5.92 - $8.35 $5,564 - $7,849
940 Added 22.74%
5,073 $38,000
Q2 2018

Aug 15, 2018

SELL
$4.86 - $6.24 $62,290 - $79,978
-12,817 Reduced 75.62%
4,133 $25,000
Q1 2018

May 15, 2018

BUY
$5.75 - $7.97 $41,014 - $56,850
7,133 Added 72.66%
16,950 $99,000
Q4 2017

Feb 09, 2018

SELL
$4.46 - $6.45 $8,126 - $11,751
-1,822 Reduced 15.65%
9,817 $58,000
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.49 $41,318 - $63,898
11,639
11,639 $59,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.